Bex4, or Brain Expressed X-Linked 4, is a member of the BEX family of genes and encodes a protein that plays a crucial role in neurodevelopment and cellular processes in mice. Although the complete biological functions of Bex4 are not fully understood, research suggests that it may be involved in the regulation of the cell cycle and interact with structural components of the cell such as alpha-tubulin. The expression of Bex4 is critical for maintaining normal cellular functions, and alterations in its expression levels can have significant effects on cellular dynamics. Given its importance in cellular homeostasis, understanding the regulation of Bex4 expression is a focal point of interest in molecular biology.
A variety of chemical compounds have the potential to act as activators of Bex4 expression. For instance, compounds that modify the epigenetic landscape, such as DNA methyltransferase inhibitors like 5-Aza-2'-deoxycytidine, can upregulate Bex4 by promoting the demethylation of its promoter region, thereby enhancing gene transcription. Histone deacetylase inhibitors, including Trichostatin A and Valproic acid, could similarly elevate Bex4 expression by inducing a more open chromatin state, facilitating the access of transcriptional machinery to the Bex4 gene. Moreover, compounds that perturb microtubule stability, such as Paclitaxel and Nocodazole, may also stimulate the expression of Bex4, potentially as part of the cellular response to altered cytoskeletal dynamics. Additionally, small molecules like Forskolin, which increases intracellular cAMP levels, could potentially promote Bex4 expression via cAMP response element-binding protein (CREB)-mediated transcription. Other agents such as Sodium butyrate, Lithium chloride, natural compounds like Epigallocatechin gallate (EGCG), and Resveratrol, have also been hypothesized to induce Bex4 expression through various mechanisms, including the modulation of signaling pathways and changes in histone modification patterns. Lastly, agents that mimic cellular stress conditions, such as 2-Deoxy-D-glucose, could potentially trigger a protective response upregulating Bex4 among other stress response genes. Each of these activators operates through distinct molecular mechanisms, reflecting the multifaceted regulation of gene expression and the complex nature of cellular homeostasis.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
This compound could upregulate Bex4 by demethylating promoter regions of the gene, leading to increased transcription in neuronal tissue. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A may enhance acetylation levels, thereby stimulating the transcriptional activity of Bex4. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid may upregulate Bex4 through its histone deacetylase inhibitory activity, which can result in a more relaxed chromatin structure favoring gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can induce Bex4 expression during developmental processes by activating retinoic acid receptors that bind to Bex4 gene regulatory regions. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Taxol may stimulate Bex4 expression by stabilizing microtubules, which could trigger a compensatory response upregulating microtubule-associated proteins. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole could upregulate Bex4 as a response to disrupted microtubule dynamics, initiating a cellular reaction to stabilize the cytoskeleton. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may stimulate Bex4 expression by raising intracellular cAMP levels, which might activate protein kinase A and lead to enhanced transcriptional activity of Bex4. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylase, may induce higher expression levels of Bex4, potentially increasing gene activation in the central nervous system. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could upregulate Bex4 expression by inhibiting GSK-3β, leading to altered transcription factor activity and increased gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate may upregulate Bex4 by altering histone acetylation patterns, which could enhance the transcription of genes involved in neuronal survival and repair. | ||||||